Average Co-Inventor Count = 4.00
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Precision Biologics, Inc. (6 from 29 patents)
2. Neogenix Oncology, Inc. (1 from 3 patents)
7 patents:
1. 12460013 - Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
2. 11572413 - Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
3. 10364295 - Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
4. 9605077 - Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
5. 9169326 - Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
6. 8535667 - Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
7. 7314622 - Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers